• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV-2 变异株在欧洲国家中的替代数学建模:传播动力学和流行病学见解。

Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights.

机构信息

Computational Biology and Complex Systems Group, Department of Physics, Universitat Politècnica de Catalunya, Barcelona, Spain.

Microbiology Department, Vall D'Hebron Hospital Universitari, Vall D'Hebron Institut de Recerca, Vall D'Hebron Barcelona Hospital Campus, Barcelona, Spain.

出版信息

Front Public Health. 2024 May 15;12:1339267. doi: 10.3389/fpubh.2024.1339267. eCollection 2024.

DOI:10.3389/fpubh.2024.1339267
PMID:38855458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11160439/
Abstract

BACKGROUND

Countries across Europe have faced similar evolutions of SARS-CoV-2 variants of concern, including the Alpha, Delta, and Omicron variants.

MATERIALS AND METHODS

We used data from GISAID and applied a robust, automated mathematical substitution model to study the dynamics of COVID-19 variants in Europe over a period of more than 2 years, from late 2020 to early 2023. This model identifies variant substitution patterns and distinguishes between residual and dominant behavior. We used weekly sequencing data from 19 European countries to estimate the increase in transmissibility    between consecutive SARS-CoV-2 variants. In addition, we focused on large countries with separate regional outbreaks and complex scenarios of multiple competing variants.

RESULTS

Our model accurately reproduced the observed substitution patterns between the Alpha, Delta, and Omicron major variants. We estimated the daily variant prevalence and calculated between variants, revealing that: ( ) increased progressively from the Alpha to the Omicron variant; ( ) showed a high degree of variability within Omicron variants; ( ) a higher was associated with a later emergence of the variant within a country; ( ) a higher degree of immunization of the population against previous variants was associated with a higher for the Delta variant; ( ) larger countries exhibited smaller  suggesting regionally diverse outbreaks within the same country; and finally ( ) the model reliably captures the dynamics of competing variants, even in complex scenarios.

CONCLUSION

The use of mathematical models allows for precise and reliable estimation of daily cases of each variant. By quantifying  we have tracked the spread of the different variants across Europe, highlighting a robust increase in transmissibility trend from Alpha to Omicron. Additionally, we have shown that the geographical characteristics of a country, as well as the timing of new variant entrances, can explain some of the observed differences in variant substitution dynamics across countries.

摘要

背景

欧洲各国都经历了 SARS-CoV-2 变异株的相似演变,包括 Alpha、Delta 和 Omicron 变异株。

材料与方法

我们使用 GISAID 数据,并应用稳健、自动的数学替代模型,研究了 2020 年末至 2023 年初超过 2 年期间欧洲 COVID-19 变异株的动态。该模型确定了变异株替代模式,并区分了残余和主导行为。我们使用来自 19 个欧洲国家的每周测序数据,估计了连续 SARS-CoV-2 变异株之间的传染性增加。此外,我们还关注了具有单独区域性暴发和多种竞争变异株复杂情况的大国。

结果

我们的模型准确地再现了 Alpha、Delta 和 Omicron 主要变异株之间观察到的替代模式。我们估计了每日变异株流行率,并计算了变异株之间的 ,结果表明:( ) 从 Alpha 变异株到 Omicron 变异株逐渐增加;( ) Omicron 变异株内的 具有高度变异性;( ) 较高的 与该变异株在一个国家内的较晚出现相关;( ) 对先前变异株的更高程度免疫与对 Delta 变异株的更高 相关;( ) 较大的国家表现出较小的  表明同一国家内区域性不同暴发;最后( )即使在复杂情况下,该模型也能可靠地捕捉竞争变异株的动态。

结论

使用数学模型可以精确可靠地估计每种变异株的每日病例数。通过量化  我们追踪了不同变异株在欧洲的传播情况,突出了从 Alpha 变异株到 Omicron 变异株的传染性增加趋势。此外,我们还表明,一个国家的地理特征以及新变异株进入的时间,可以解释一些国家间变异株替代动态观察到的差异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/821906415c75/fpubh-12-1339267-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/8914019a3c3d/fpubh-12-1339267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/109dbdb26159/fpubh-12-1339267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/9bd189ee4acf/fpubh-12-1339267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/0b7ef03c6b23/fpubh-12-1339267-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/15ba1cde80cf/fpubh-12-1339267-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/9814d2062330/fpubh-12-1339267-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/fa1d9bca5c03/fpubh-12-1339267-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/0fa2b891da49/fpubh-12-1339267-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/821906415c75/fpubh-12-1339267-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/8914019a3c3d/fpubh-12-1339267-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/109dbdb26159/fpubh-12-1339267-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/9bd189ee4acf/fpubh-12-1339267-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/0b7ef03c6b23/fpubh-12-1339267-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/15ba1cde80cf/fpubh-12-1339267-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/9814d2062330/fpubh-12-1339267-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/fa1d9bca5c03/fpubh-12-1339267-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/0fa2b891da49/fpubh-12-1339267-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fb67/11160439/821906415c75/fpubh-12-1339267-g009.jpg

相似文献

1
Mathematical modeling of SARS-CoV-2 variant substitutions in European countries: transmission dynamics and epidemiological insights.SARS-CoV-2 变异株在欧洲国家中的替代数学建模:传播动力学和流行病学见解。
Front Public Health. 2024 May 15;12:1339267. doi: 10.3389/fpubh.2024.1339267. eCollection 2024.
2
Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.在缓慢和快速流行疫情中选择感染性特征,以及 SARS-CoV-2 变体的出现。
Elife. 2022 May 19;11:e75791. doi: 10.7554/eLife.75791.
3
Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?奥密克戎变异株比德尔塔变异株更致命且更具传染性吗?
Int J Environ Res Public Health. 2022 Apr 11;19(8):4586. doi: 10.3390/ijerph19084586.
4
Baseline Sequencing Surveillance of Public Clinical Testing, Hospitals, and Community Wastewater Reveals Rapid Emergence of SARS-CoV-2 Omicron Variant of Concern in Arizona, USA.美国亚利桑那州公共临床检测、医院和社区污水的基线测序监测显示,SARS-CoV-2 关注的奥密克戎变异株迅速出现。
mBio. 2023 Feb 28;14(1):e0310122. doi: 10.1128/mbio.03101-22. Epub 2023 Jan 9.
5
Comparison of epidemiological characteristics and transmissibility of different strains of COVID-19 based on the incidence data of all local outbreaks in China as of March 1, 2022.基于截至 2022 年 3 月 1 日中国所有本地疫情的发病数据,比较不同 COVID-19 株的流行病学特征和传播性。
Front Public Health. 2022 Sep 15;10:949594. doi: 10.3389/fpubh.2022.949594. eCollection 2022.
6
Overlapping Delta and Omicron Outbreaks During the COVID-19 Pandemic: Dynamic Panel Data Estimates.新冠大流行期间 Delta 和奥密克戎变异株的叠加流行:动态面板数据估计。
JMIR Public Health Surveill. 2022 Jun 3;8(6):e37377. doi: 10.2196/37377.
7
Retrospective analysis of SARS-CoV-2 omicron invasion over delta in French regions in 2021-22: a status-based multi-variant model.2021-22 年法国地区 SARS-CoV-2 奥密克戎对德尔塔入侵的回顾性分析:基于状态的多变量模型。
BMC Infect Dis. 2022 Nov 3;22(1):815. doi: 10.1186/s12879-022-07821-5.
8
Development and application of an RT‒PCR assay for the identification of the delta and omicron variants of SARS-COV-2.一种用于鉴定新型冠状病毒2型(SARS-CoV-2)德尔塔和奥密克戎变异株的逆转录聚合酶链反应(RT-PCR)检测方法的开发与应用
Heliyon. 2023 Jun;9(6):e16917. doi: 10.1016/j.heliyon.2023.e16917. Epub 2023 Jun 1.
9
COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination.印度的新冠疫情动态、严重急性呼吸综合征冠状病毒2(SARS-CoV-2)德尔塔变异株及其对疫苗接种的影响
medRxiv. 2021 Nov 22:2021.06.21.21259268. doi: 10.1101/2021.06.21.21259268.
10
Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.非药物干预措施、疫苗接种和 SARS-CoV-2 德尔塔变异株在英国:一项数学建模研究。
Lancet. 2021 Nov 13;398(10313):1825-1835. doi: 10.1016/S0140-6736(21)02276-5. Epub 2021 Oct 28.

引用本文的文献

1
Identification of Clinical and Genomic Features Associated with SARS-CoV-2 Reinfections.与新型冠状病毒再次感染相关的临床和基因组特征识别
Viruses. 2025 Jun 11;17(6):840. doi: 10.3390/v17060840.
2
Severity of Omicron Subvariants and Vaccine Impact in Catalonia, Spain.西班牙加泰罗尼亚地区奥密克戎亚变体的严重程度及疫苗影响
Vaccines (Basel). 2024 Apr 27;12(5):466. doi: 10.3390/vaccines12050466.

本文引用的文献

1
Country-report pattern corrections of new cases allow accurate 2-week predictions of COVID-19 evolution with the Gompertz model.国家报告模式修正新病例,使基于戈珀兹模型的 COVID-19 演变的准确两周预测成为可能。
Sci Rep. 2024 May 11;14(1):10775. doi: 10.1038/s41598-024-61233-w.
2
SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and convalescent immunity.SARS-CoV-2 变异株的传播动态与疫苗接种率、共同传播变异株的数量以及康复后的免疫能力有关。
EBioMedicine. 2023 May;91:104534. doi: 10.1016/j.ebiom.2023.104534. Epub 2023 Mar 31.
3
The outbreak of SARS-CoV-2 Omicron lineages, immune escape, and vaccine effectivity.
奥密克戎变异株引发的 SARS-CoV-2 疫情、免疫逃逸和疫苗效力。
J Med Virol. 2023 Jan;95(1):e28138. doi: 10.1002/jmv.28138. Epub 2022 Sep 21.
4
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.疫苗对 Alpha、Delta 或奥密克戎变异株引起的 SARS-CoV-2 感染或 COVID-19 住院的有效性:一项全国性丹麦队列研究。
PLoS Med. 2022 Sep 1;19(9):e1003992. doi: 10.1371/journal.pmed.1003992. eCollection 2022 Sep.
5
Transmissibility, hospitalization, and intensive care admissions due to omicron compared to delta variants of SARS-CoV-2 in Catalonia: A cohort study and ecological analysis.与 SARS-CoV-2 的德尔塔变异株相比,奥密克戎变异株在加泰罗尼亚导致的传染性、住院和重症监护病房入住率:一项队列研究和生态学分析。
Front Public Health. 2022 Aug 12;10:961030. doi: 10.3389/fpubh.2022.961030. eCollection 2022.
6
Omicron: increased transmissibility and decreased pathogenicity.奥密克戎:传播性增强,致病性减弱。
Signal Transduct Target Ther. 2022 May 7;7(1):151. doi: 10.1038/s41392-022-01009-8.
7
SARS-CoV-2 Omicron variant: recent progress and future perspectives.SARS-CoV-2 奥密克戎变异株:最新进展与未来展望。
Signal Transduct Target Ther. 2022 Apr 28;7(1):141. doi: 10.1038/s41392-022-00997-x.
8
Comparative transmissibility of SARS-CoV-2 variants Delta and Alpha in New England, USA.美国新英格兰地区 SARS-CoV-2 变异株 Delta 和 Alpha 的比较传染性。
Cell Rep Med. 2022 Mar 11;3(4):100583. doi: 10.1016/j.xcrm.2022.100583. eCollection 2022 Apr 19.
9
Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants.阿尔法(B.1.1.7)和德尔塔(B.1.617.2)变异株之间的传播差异。
Microbiol Spectr. 2022 Apr 27;10(2):e0000822. doi: 10.1128/spectrum.00008-22. Epub 2022 Apr 12.
10
Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant.Covid-19 疫苗对奥密克戎(B.1.1.529)变异株的有效性。
N Engl J Med. 2022 Apr 21;386(16):1532-1546. doi: 10.1056/NEJMoa2119451. Epub 2022 Mar 2.